218 related articles for article (PubMed ID: 29246117)
1. Prognostic significance of RBP2-H1 variant of JARID1B in melanoma.
Kuźbicki Ł; Lange D; Stanek-Widera A; Chwirot BW
BMC Cancer; 2017 Dec; 17(1):854. PubMed ID: 29246117
[TBL] [Abstract][Full Text] [Related]
2. Altered Splicing of JARID1B in Development of Human Cutaneous Melanoma?
Kuźbicki Ł; Lange D; Strączyńska-Niemiec A; Chwirot BW
Appl Immunohistochem Mol Morphol; 2016 Mar; 24(3):188-92. PubMed ID: 25789538
[TBL] [Abstract][Full Text] [Related]
3. RBP2-H1/JARID1B is a transcriptional regulator with a tumor suppressive potential in melanoma cells.
Roesch A; Mueller AM; Stempfl T; Moehle C; Landthaler M; Vogt T
Int J Cancer; 2008 Mar; 122(5):1047-57. PubMed ID: 17973255
[TBL] [Abstract][Full Text] [Related]
4. Re-expression of the retinoblastoma-binding protein 2-homolog 1 reveals tumor-suppressive functions in highly metastatic melanoma cells.
Roesch A; Becker B; Schneider-Brachert W; Hagen I; Landthaler M; Vogt T
J Invest Dermatol; 2006 Aug; 126(8):1850-9. PubMed ID: 16645588
[TBL] [Abstract][Full Text] [Related]
5. JARID1B expression in human melanoma and benign melanocytic skin lesions.
Kuźbicki L; Lange D; Strączyńska-Niemiec A; Chwirot BW
Melanoma Res; 2013 Feb; 23(1):8-12. PubMed ID: 23262439
[TBL] [Abstract][Full Text] [Related]
6. Histone demethylase JARID1B/KDM5B promotes aggressiveness of non-small cell lung cancer and serves as a good prognostic predictor.
Kuo KT; Huang WC; Bamodu OA; Lee WH; Wang CH; Hsiao M; Wang LS; Yeh CT
Clin Epigenetics; 2018 Aug; 10(1):107. PubMed ID: 30092824
[TBL] [Abstract][Full Text] [Related]
7. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.
Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT
Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998
[TBL] [Abstract][Full Text] [Related]
8. JARID1B protein expression and prognostic implications in uveal melanoma.
Radberger P; Radberger A; Bykov VJ; Seregard S; Economou MA
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4442-9. PubMed ID: 22669717
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of JARID1B is associated with poor prognosis and chemotherapy resistance in epithelial ovarian cancer.
Wang L; Mao Y; Du G; He C; Han S
Tumour Biol; 2015 Apr; 36(4):2465-72. PubMed ID: 25663457
[TBL] [Abstract][Full Text] [Related]
10. Histone Demethylase JARID1B Is Overexpressed in Osteosarcoma and Upregulates Cyclin D1 Expression via Demethylation of H3K27me3.
Wang W; Zheng K; Pei Y; Zhang X
Oncol Res; 2018 Apr; 26(3):373-384. PubMed ID: 28492139
[TBL] [Abstract][Full Text] [Related]
11. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth.
Roesch A; Fukunaga-Kalabis M; Schmidt EC; Zabierowski SE; Brafford PA; Vultur A; Basu D; Gimotty P; Vogt T; Herlyn M
Cell; 2010 May; 141(4):583-94. PubMed ID: 20478252
[TBL] [Abstract][Full Text] [Related]
12. Jumonji AT-rich interactive domain 1B overexpression is associated with the development and progression of glioma.
Fang L; Zhao J; Wang D; Zhu L; Wang J; Jiang K
Int J Mol Med; 2016 Jul; 38(1):172-82. PubMed ID: 27246838
[TBL] [Abstract][Full Text] [Related]
13. The human melanoma side population displays molecular and functional characteristics of enriched chemoresistance and tumorigenesis.
Wouters J; Stas M; Gremeaux L; Govaere O; Van den Broeck A; Maes H; Agostinis P; Roskams T; van den Oord JJ; Vankelecom H
PLoS One; 2013; 8(10):e76550. PubMed ID: 24098529
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Jumonji AT-rich interactive domain 1B and PHD finger protein 2 is involved in the progression of esophageal squamous cell carcinoma.
Sun LL; Sun XX; Xu XE; Zhu MX; Wu ZY; Shen JH; Wu JY; Huang Q; Li EM; Xu LY
Acta Histochem; 2013 Jan; 115(1):56-62. PubMed ID: 22534467
[TBL] [Abstract][Full Text] [Related]
15. Androgen receptor activation by polychlorinated biphenyls: epigenetic effects mediated by the histone demethylase Jarid1b.
Casati L; Sendra R; Poletti A; Negri-Cesi P; Celotti F
Epigenetics; 2013 Oct; 8(10):1061-8. PubMed ID: 23907094
[TBL] [Abstract][Full Text] [Related]
16. Histone demethylase JARID1B promotes cell proliferation but is downregulated by N-Myc oncoprotein.
Zhang L; Sokolowski N; Atmadibrata B; Liu T
Oncol Rep; 2014 Apr; 31(4):1935-9. PubMed ID: 24481781
[TBL] [Abstract][Full Text] [Related]
17. Jumonji/ARID1 B (JARID1B) protein promotes breast tumor cell cycle progression through epigenetic repression of microRNA let-7e.
Mitra D; Das PM; Huynh FC; Jones FE
J Biol Chem; 2011 Nov; 286(47):40531-5. PubMed ID: 21969366
[TBL] [Abstract][Full Text] [Related]
18. Histone demethylase JARID1B/KDM5B is a corepressor of TIEG1/KLF10.
Kim J; Shin S; Subramaniam M; Bruinsma E; Kim TD; Hawse JR; Spelsberg TC; Janknecht R
Biochem Biophys Res Commun; 2010 Oct; 401(3):412-6. PubMed ID: 20863814
[TBL] [Abstract][Full Text] [Related]
19. Targeting the H3K4 Demethylase KDM5B Reprograms the Metabolome and Phenotype of Melanoma Cells.
Vogel FCE; Bordag N; Zügner E; Trajkovic-Arsic M; Chauvistré H; Shannan B; Váraljai R; Horn S; Magnes C; Thomas Siveke J; Schadendorf D; Roesch A
J Invest Dermatol; 2019 Dec; 139(12):2506-2516.e10. PubMed ID: 31229500
[TBL] [Abstract][Full Text] [Related]
20. Depletion of JARID1B induces cellular senescence in human colorectal cancer.
Ohta K; Haraguchi N; Kano Y; Kagawa Y; Konno M; Nishikawa S; Hamabe A; Hasegawa S; Ogawa H; Fukusumi T; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Noguchi Y; Ozaki M; Kudo T; Sakai D; Satoh T; Fukami M; Ishii M; Yamamoto H; Doki Y; Mori M; Ishii H
Int J Oncol; 2013 Apr; 42(4):1212-8. PubMed ID: 23354547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
